| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.03 |